At HyperSpeed LASIK (https://lnkd.in/giqV5jfE), an NVISION® Eye Center, they promise custom care, an exceptional experience, and life-changing results—all delivered in a patient-centric environment. Renowned surgeon Dagny Zhu, M.D., and her team use MydCombi to dilate their patients. Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi Contraindications: Known hypersensitivity to any component of the formulation. See Full Prescribing Information Here: https://bit.ly/4btbPHk
Eyenovia, Inc.
Pharmaceutical Manufacturing
New York, New York 6,383 followers
FDA Approved Drug-Device Ophthalmic Company
About us
Eyenovia, Inc. (NASDAQ: EYEN), is an ophthalmic technology company developing the Optejet® device for use both in connection with its own drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia as well as out-licensing for additional indications.
- Website
-
http://eyenovia.com
External link for Eyenovia, Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- New York, New York
- Type
- Public Company
- Founded
- 2014
- Specialties
- Ophthalmology, optometry, presbyopia, technology, innovation, mydriasis, manufacturing, pharmaceutical, glaucoma, dry eye, healthcare, myopia, disruptive, and lifestyle
Locations
-
Primary
295 Madison Ave
Suite 2400
New York, New York 10017, US
Employees at Eyenovia, Inc.
Updates
-
Woolfson Eye Institute https://lnkd.in/gm8x5Yp8 is led by LASIK pioneer, Jonathan Woolfson, MD. Along with the other surgeons in their practice, Woolfson Eye has performed over 100,000 LASIK procedures. Over 300 eye doctors have chosen Dr. Woolfson to perform their LASIK, showcasing his expertise. In addition to being a LASIK pioneer, Woolfson Eye has recently implemented MydCombi for dilation - envisioning a better patient experience. Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi Contraindications: Known hypersensitivity to any component of the formulation. See Full Prescribing Information Here: https://bit.ly/4btbPHk
-
-
Everything is bigger in Texas, especially the launch of MydCombi with the optometrists at Lakeline Vision Source in Cedar Park, Texas. Led by its founder Laurie Sorrenson OD, FAAO, the team grabbed MydCombi by the horns during their implementation training! Lakeline is dedicated to providing patients with the best eye care available using the latest technological equipment available to diagnose better and treat their patients. They choose MydCombi to dilate their patients. Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi Contraindications: Known hypersensitivity to any component of the formulation. See Full Prescribing Information Here: https://bit.ly/4btbPHk
-
-
Eyenovia is very fortunate to have incredible support from our partners at Formosa Pharmaceuticals, Inc. Here's to making it possible! #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #steroid #surgery #cataract See Full Prescribing Information Here: https://lnkd.in/gWYjgSiN
Formosa Pharmaceuticals, Inc. CB&SO/ I help pharmaceutical companies to explore new possibility and new opportunities, via APNT formulation Platform, ophthalmology innovations and Biosimilar.
I am excited to share Eyenovia, Inc., Formosa Pharmaceuticals, Inc.'s partner's new sites with everyone. A big thank you to Eyenovia for highlighting the benefits of Clobetasol Propionate Ophthalmic Suspension 0.05% (APP13007) for pain and inflammation post ocular surgery in a concise and impressive manner. Looking forward to the upcoming US launch. #Clobetasolbid #APP13007 #OcularSurgery #6838FormosaPharma https://eyenovia.com/ https://clobetasolbid.com/
-
-
Hear from CEO, Michael Rowe, as he showcases the incredible progress made and upcoming events we have planned. Watch How We Make It Possible: https://bit.ly/4cnRKCH (Click the first home page slide) #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi
-
-
Gregory L. Bittner, O.D., - https://lnkd.in/gvH3Bb7P - has been a leading provider of optometry services and vision care products in the Somerset, PA community since 1984. This office uses advanced diagnostic technology and vision correction products and is committed to improving patients' quality of life. They choose MydCombi to dilate their patients. Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi Contraindications: Known hypersensitivity to any component of the formulation. See Full Prescribing Information Here: https://bit.ly/4btbPHk
-
-
MydCombi (tropicamide 1% and phenylephrine hydrochloride 2.5%) is now available nationwide! Introduce your patients to the experience of modern mydriasis by visiting EyenoviaRx. Start now: bit.ly/ERxNew Learn more about MydCombi: bit.ly/mydcombi #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi Contraindications: Known hypersensitivity to any component of the formulation. See Full Prescribing Information Here: bit.ly/4btbPHk
-
Gulani Vision Institute https://lnkd.in/gqgmUFqD founded by Arun Gulani, M.D., in Jacksonville, FL, is a world destination for patients and surgeons seeking the best in vision care. The institute combines advanced technology with individualized surgical plans to ensure the best patient outcomes. They choose MydCombi (tropicamide 1% and phenylephrine hydrochloride 2.5%) to dilate their patients. Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi Contraindications: Known hypersensitivity to any component of the formulation. See Full Prescribing Information Here: https://bit.ly/4btbPHk
-
-
At Everett Eye Care Center - https://lnkd.in/dT6PAYWD - Jessica S. Stone, O.D., provides a comfortable and modern eye care experience for her patients by bringing in the latest technologies available into her practice. She chooses MydCombi (tropicamide 1% and phenylephrine hydrochloride 2.5%) to dilate her patients. Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi Contraindications: Known hypersensitivity to any component of the formulation. See Full Prescribing Information Here: https://bit.ly/4btbPHk
-
-
A.R Morris, O.D. & Associates - https://lnkd.in/g8wU2Ps5 - has been serving the community of Ebensburg, PA since 1984. Their practice, run by father-daughter duo A.R. Morris O.D., and Katie Morris, O.D., is committed to improving the quality of life of their community members with enhanced vision by using advanced diagnostic equipment. They choose MydCombi to dilate their patients. Learn how Eyenovia is making it possible by visiting https://bit.ly/3Dik87F #ophthalmology #optometry #eyenovia #optejet #drugdevice #technology #tech #investing #innovation #startups #mydcombi Contraindications: Known hypersensitivity to any component of the formulation. See Full Prescribing Information Here: https://bit.ly/4btbPHk
-